Overview / Abstract: |
STATEMENT OF NEED Myelodysplastic syndromes (MDS) are a group of heterogeneous hematopoietic disorders derived from an abnormal multipotent progenitor cell, characterized by ineffective hematopoiesis, bone marrow failure, and peripheral blood cytopenias. Survival in MDS ranges from a median of 5.3 years in lower-risk patients to as little as 0.8 years in higher-risk patients. Mortality is usually a result of infection, hemorrhage, and/or iron overload secondary to red blood cell transfusions. Approximately 30% of patients with MDS progress to acute myeloid leukemia (AML). The estimated annual age-adjusted incidence of MDS in the United States is 3 to 4 cases per 100,000 individuals, with approximately 14,011 new cases per year. Considering the aging population, the incidence of MDS will likely grow in persons older than 60 years of age. TARGET AUDIENCE Hematology/oncology physicians, pathologists, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients with MDS. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: 1.) Assess patient and tumor characteristics that can inform personalized care plans for patients with MDS |
Expiration |
May 20, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 CME/NCPD |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
David P. Steensma, MD, FACP (Chairperson) Reza Nejati, MD Ilene Galinsky, BSN, MSN, ANP-C |
Activity Specialities / Related Topics |
Hematology, Pathology, Transplant Medicine |
Sponsors / Supporters / Grant Providers |
This activity is supported by independent educational grants from Takeda Oncology and Taiho Oncology, Inc. |
Keywords / Search Terms |
i3 Health i3 Health, multiple myeloma, MM, online CNE, free CNE, free CE CME, free CE CME, free CE CME, NCPD, free NCPD, online NCPD, online NCPD CME, free CE CME Free CE CME |